SCHEMBL13435255

SCHEMBL13435255

COC(=O)CN(CC(=O)OC)c1ccccc1OCCOCCOc1ccccc1N(CC(=O)OC)CC(=O)OC

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.64
ALDH1A1 P00352 7/20 0.49
KDM4E B2RXH2 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
LMNA P02545 2/20 0.49
KMT2A Q03164 3/20 0.46
PTK2B Q14289 1/20 0.46
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
POLB P06746 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 2/20 0.40
PPARG P37231 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30069487 0.95 TDP1 (0.69) TDP1ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL19557489 0.93 TDP1 (0.57) TDP1ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL13230077 0.89 TDP1 (0.61) TDP1ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL13435254 0.87 TDP1 (0.51) TDP1ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL14654334 0.86 TDP1 (0.59) TDP1ALDH1A1KDM4ESMN1; SMN2KMT2A
SCHEMBL14654314 0.85 TDP1 (0.57) TDP1ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL16855860 0.84 TDP1 (0.56) TDP1ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL23029083 0.83 TDP1 (0.55) TDP1ALDH1A1LMNAKMT2AMTNR1A
SCHEMBL10378725 0.83 TDP1 (0.57) TDP1ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL16982683 0.83 TDP1 (0.52) TDP1ALDH1A1SMN1; SMN2KMT2AMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100068748-A1 Fluorescent Ion Indicators for Cadmium and Lanthanide Ion Detection INVITROGEN CORPORATION (US) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100068748-A1 Fluorescent Ion Indicators for Cadmium and Lanthanide Ion Detection SLC30A6, SLC39A14, SLC39A7 TDP1 3745/4885ALDH1A1 1607/4885KDM4E 3136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.